FindTrial
Sign In

Homeopathic treatment of common cold in children

Individualized homeopathic medicines in upper respiratory tract infections in children: Double-blind, randomized, placebo-controlled pilot trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038881
Enrollment
60
Registered
2021-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies: Intervention is planned as administering individualized homeopathic medicines in centesimal potencies. Each dose will consi
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking or brushing teeth within 30 minute

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinical signs and symptoms of an upper respiratory tract infections with a duration of greater than or equal to 24 hours with or without fever greater than or equal to 37.5 degree Celsius. 2. At least 1 of 3 types of upper respiratory tract infections symptoms ââ?¬â?? nasal (plugged nose, runny nose, sneezing), pharyngeal (scratchy throat, sore throat, pharyngeal hyperemia), and cough (ordinary cough without suspicion of acute lower respiratory tract disease). 3. At least 1 of 5 general symptoms ââ?¬â?? feeling tired, weakness, body ache, irritable or whiney, or less active. 4. Literate guardians or attendants capable of understanding and filling the questionnaire and providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe or complicated course of upper respiratory tract infections. 2. Signs of acute lower respiratory tract infections. 3. COVID-19 positive cases. 4. Current symptoms mainly induced by other acute ear, nose, throat diseases. 5. Daily use of antibiotics, steroids and cytotoxic agents. 6. Immune-compromised state. 8. Already undergoing homeopathic or other modes of treatment for upper respiratory tract infections.

Design outcomes

Primary

MeasureTime frame
Number of patients in each group showing complete disappearance of the symptoms of upper respiratory tract infection.Timepoint: Baseline and after 4, 8 and 15 days—

Secondary

MeasureTime frame
Upper respiratory tract infection symptom severity scale (URI-SSS)Timepoint: Baseline and after 4, 8 and 15 days;Wisconsin Upper Respiratory Symptom Survey (WURSS-21)Timepoint: Baseline and after 4, 8 and 15 days—

Countries

India

Contacts

Public ContactTarikul Mondal

D N De Homoeopathic Medical College & Hospital

dr.sangita78@gmail.com9433849505

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026